Do you want to read an article? Please log in or register.
Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors-Results from the Swiss IBD Cohort Study
Inflammatory Bowel Disease
Related content
Inflammatory Bowel Disease
Dietary risk factors for inflammatory bowel diseases in a high-risk population: Results from the Faroese IBD study
United European Gastroenterol J.
Hammer T, Lophaven SN, Nielsen KR, Petersen MS, Munkholm P, Weihe P, Burisch J, Lynge E
doi: 10.1177/2050640619852244.
RECOMMENDED
Inflammatory Bowel Disease
Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study
Inflamm Bowel Dis.
Biancone L, Armuzzi A, Scribano ML, Castiglione F, D'incà R, Orlando A, Papi C, Daperno M, Vecchi M, Riegler G, Fries W, Alvisi P, Meucci G, Mocciaro F, Rogai F, Festa S, Guidi L, Testa A, Spina L, Renna S, Viola A, Patturelli M, Di Mitri R, Frankovic I, Calabrese E, Petruzziello C, De Cristofaro E, Sena G, Ruffa A, Neri B, Rossi A, Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).
doi: 10.1093/ibd/izz155.
Inflammatory Bowel Disease
Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort
Eur J Gastroenterol Hepatol.
Godat S, Fournier N, Safroneeva E, Juillerat P, Nydegger A, Straumann A, Vavricka S, Biedermann L, Greuter T, Fraga M, Abdelrahman K, Hahnloser D, Sauter B, Rogler G, Michetti P, Schoepfer AM, Swiss IBD Cohort Study Group
doi: 10.1097/MEG.
Inflammatory Bowel Disease
The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort
Inflamm Bowel Dis.
Madanchi M, Fagagnini S, Fournier N, Biedermann L, Zeitz J, Battegay E, Zimmerli L, Vavricka SR, Rogler G, Scharl M; Swiss IBD Cohort Study Group.
doi: 10.1093/ibd/izy054.
Inflammatory Bowel Disease
Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort study
Therap Adv Gastroenterol.
Grob L, Bluemel S, Biedermann L, Fournier N, Rossel JB, Vavricka SR, Zeitz J, Rogler G, Stallmach A, Scharl M
doi: 10.1177/1756284819895217.
COMMENTED
Inflammatory Bowel Disease
Genetic risk factors predict disease progression in Crohn's disease patients of the Swiss inflammatory bowel disease cohort
★ 2
Recommended and commented by
Prof. Dr Stephan Vavricka, Faculty Member
Therap Adv Gastroenterol
Ditrich F, Blümel S, Biedermann L, Fournier N, Rossel JB, Ellinghaus D, Franke A, Stange EF, Rogler G, Scharl M, Swiss IBD Cohort Study Group.
doi: 10.1177/1756284820959252
Inflammatory Bowel Disease
Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study
PLoS One.
Roth N, Biedermann L, Fournier N, Butter M, Vavricka SR, Navarini AA, Rogler G, Scharl M; Swiss IBD Cohort Study Group
doi: 10.1371/journal.pone.0210436.
COMMENTED
Inflammatory Bowel Disease
Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort
★ 1
Recommended and commented by
Prof. Dr Stephan Vavricka, Faculty Member
United European Gastroenterol J
Greuter T, Porchet F, Braga-Neto MB, Rossel JB, Biedermann L, Schreiner P, Scharl M, Schoepfer AM, Safroneeva E, Straumann A, Rogler G, Vavricka SR
doi: 10.1177/2050640620954556
RECOMMENDED
Inflammatory Bowel Disease
Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort - an Epi-IBD study
doi: 10.1111/jgh.14563.